P. Panday: IVF Services Market Set to Reach $34 Billion by 2030
P. Panday, Senior Fertility Specialist at Vatsalya IVF, shared on LinkedIn:
“IVF services market set to reach $34 billion by 2030!
The IVF services market is poised for significant expansion, supported by rising fertility challenges and advancements in IVF technologies, including personalized treatment approaches and integrated patient care solutions.
Projected to surpass $34 billion by 2029, the IVF services market represents an important segment of the broader fertility services market, which is expected to reach approximately $124 billion during the same period. Within the larger healthcare services industry, forecasted to reach $10,759 billion by 2029, IVF services will account for nearly 0.3% of the total market.
North America is expected to maintain the leading position in the IVF services market by 2029, reaching an estimated value of $10,563 million and growing at a compound annual growth rate (CAGR) of 12%. This regional growth is driven by delayed parenthood trends and favorable government support for fertility treatments.
The United States is projected to remain the largest country market, valued at $9,717 million, supported by lifestyle-related fertility challenges and supportive regulatory approvals for IVF procedures.
The market is led by fresh IVF cycles (non-donor), which are expected to account for 45% or $15,393 million of the market by 2029. Fertility clinics are projected to dominate the service segment, representing 77% or $26,219 million during the same period. Growth in these areas is being encouraged by rising IVF awareness, advancements in embryo culture technologies, increasing trends of delayed childbearing, and improved access to specialized fertility equipment and professionals.
Key players include
- Monash IVF Group
- IVIRMA Italia
- Thomson Medical
The IVF services market includes a wide range of international fertility clinic networks, specialized reproductive healthcare providers, and regional IVF centers. These organizations are strengthening their market positions by adopting advanced assisted reproductive technologies, enhancing treatment success rates, and delivering personalized care experiences for patients.”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic